HIV & AIDS

IDSA: Experimental Rx may be option in drug-resistant HIV

(HealthDay)—The intravenous drug ibalizumab might revolutionize the treatment of HIV patients who don't respond to existing drugs, according to research presented at the annual meeting of the Infectious Diseases Society ...

Other

Community health centers' new crisis: The need for backup power

The 2017 Tubbs Fire, which killed 22 people and destroyed 5,600 buildings, was already a stressful time at Alliance Medical Center's clinic here, as workers who picked grapes in the nearby vineyards streamed into the nonprofit ...

page 4 from 6